Effectiveness and Safety of Risankizumab Induction Therapy in Crohn's Disease: Prospective Real-World Experience in a Large Tertiary Center

被引：0
|
作者：
Zinger, Adar [1 ]
Choi, David K. [1 ]
Choi, Natalie K. [1 ]
Garcia, Nicole M. [1 ]
Cohen, Russell D. [1 ]
Dalal, Sushila [2 ]
Cleveland, Noa Krugliak [1 ]
Rubin, David T. [1 ]
机构：
[1] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA
[2] Univ Chicago Med, Chicago, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1094
引用
收藏
页码：S834 / S834
页数：1
相关论文
共 50 条
  • [31] OUTCOMES OF USTEKINUMAB IN CROHN'S DISEASE: THE REAL-WORLD EXPERIENCE OF A TERTIARY IBD CENTRE
    Miller, Bethany
    Stansfield, Catherine
    Korani, Mohamed
    Nixon, Emma
    GUT, 2021, 70 : A108 - A109
  • [32] Effectiveness and Safety of Upadacitinib Induction Therapy in Real-World Setting for 234 Patients with Crohn's Disease: A GETAID Multicentre Cohort Study
    Richard, N.
    Amiot, A.
    Seksik, P.
    Altwegg, R.
    Laharie, D.
    Vuitton, L.
    Nachury, M.
    Nancey, S.
    Bouguen, G.
    Gilletta, C.
    Rouillon, C.
    Coffin, B.
    Allez, M.
    Buisson, A.
    Le Berre, C.
    Pelletier, A. L.
    Uzzan, M.
    Caillo, L.
    Sickersen, G.
    Hupe, M.
    Abitbol, V
    Vidon, M.
    Goutorbe, F.
    Amil, M.
    Brixi, H.
    Benezech, A.
    Kwiatek, S.
    Peyrin-Biroulet, L.
    Fumery, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1948 - i1950
  • [33] Upadacitinib in Crohn's disease: real-world experience
    Mir, Adil S.
    MINERVA GASTROENTEROLOGY, 2024, 70 (04): : 442 - 445
  • [34] Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: a GETAID multicentre cohort study
    Fumery, M.
    Defrance, A.
    Roblin, X.
    Altwegg, R.
    Caron, B.
    Hebuterne, X.
    Carmen, S.
    Meyer, A.
    Nachury, M.
    Laharie, D.
    Nancey, S.
    Le Berre, C.
    Serrero, M.
    Geyl, S.
    Gilletta, C.
    Soune, P. Ah
    Duveau, N.
    Uzza, M.
    Abitbol, V.
    Biron, A.
    Minh, M. L. Tran
    Paupard, T.
    Vuitton, L.
    Elgharabawy, Y.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 770 - 770
  • [35] Risankizumab Effectiveness in Perianal Crohn's Disease: A Single Tertiary Care Center Case Series
    Belani, Seema
    Devi, Jalpa
    Jaiprada, Fnu
    Ballard, David
    Deepak, Parakkal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2538 - S2539
  • [36] Endoscopic Response to Risankizumab in Patients With Refractory Crohn's Disease Who Failed Ustekinumab - Real-World Experience
    Patel, Parth B.
    Banerjee, Debdeep
    Norwood, Dalton A.
    Ismail, Mohamed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S851 - S851
  • [37] Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study
    Fumery, Mathurin
    Defrance, Antoine
    Roblin, Xavier
    Altwegg, Romain
    Caron, Benedicte
    Hebuterne, Xavier
    Stefanescu, Carmen
    Meyer, Antoine
    Nachury, Maria
    Laharie, David
    Nancey, Stephane
    Le Berre, Catherine
    Serrero, Melanie
    Geyl, Sophie
    Giletta, Cyrielle
    Ah-Soune, Philippe
    Duveau, Nicolas
    Uzzan, Mathieu
    Abitbol, Vered
    Biron, Amelie
    My-Linh Tran-Minh
    Paupard, Thierry
    Vuitton, Lucine
    Elgharabawy, Yasmine
    Peyrin-Biroulet, Laurent
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (04) : 426 - 434
  • [38] Real-world effectiveness and safety of vedolizumab induction therapy for Crohn's disease in Poland - a prospective, observational POLONEZ II study considering patients reported outcomes.
    Liebert, A.
    Klopocka, M.
    Cichoz-Lach, H.
    Michalak, A.
    Talar-Wojnarowska, R.
    Domzal-Magrowska, D.
    Filipiuk, A.
    Krogulecki, M.
    Kopertowska-Majchrzak, M.
    Eder, P.
    Stawczyk-Eder, K.
    Waszak, K.
    Zagorowicz, E.
    Wojciechowski, K.
    Drygala, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 550 - 551
  • [39] Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn's disease: a KASID prospective multicenter study (vol 21, pg 137, 2023)
    Oh, Kyunghwan
    Hong, Hee Seung
    Ham, Nam Seok
    Lee, Jungbok
    Park, Sang Hyoung
    Yang, Suk-Kyun
    Yoon, Hyuk
    Kim, You Sun
    Choi, Chang Hwan
    Ye, Byong Duk
    INTESTINAL RESEARCH, 2023, 21 (02) : 273 - 273
  • [40] Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn’s disease
    Rajat Garg
    Manik Aggarwal
    Abdul Mohammed
    Jean Paul Achkar
    Bret Lashner
    Jessica Philpott
    Benjamin Cohen
    Taha Qazi
    Florian Rieder
    Miguel Regueiro
    Benjamin Click
    Indian Journal of Gastroenterology, 2023, 42 : 718 - 723
12345